Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03978715 · ClinicalTrials.gov registry record
The Effect of Implementing a Limb Loss Prevention Program on Amputation Rates
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 3,000
- Enrollment target
NCT03978715: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT03978715 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 3,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03978715 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
The investigators plan to do a retrospective chart review on patients admitted to Parkland Hospital with diabetic foot infections, ulcers, and bone injuries from 2005 (5 years prior to the start of the diabetic limb preservation team) to present day. The investigators will collect information on demographics, medical/surgical history, social history, medications, laboratory results, peripheral arterial disease, wound severity, and treatment factors such as type of antibiotics, off-loading, debridement, wound healing, surgery interventions, complications, recurrence, and history and physical characteristics and exam from inpatient and outpatient encounters. This will be identified by current procedural terminology (CPT) codes for foot and leg amputations, and lower extremity revascularization procedures. Clinic visits will be identified to podiatry/foot wound, vascular surgery, invasive cardiology, general surgery, and physical therapy wound care in addition to inpatient encounters of these patients to determine the full scope of care received and to compare resources utilization before and after implementation of the diabetic limb preservation team.
Primary Outcome
The number of lower limb complications per participant.
Interventions
- OTHER No intervention-retrospective study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2021-04-14 |
| Est. Completion | 2022-10-07 |
What the finished NCT03978715 record still lists
NCT03978715 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which No intervention-retrospective study is the first listed.
NCT03978715 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03978715 about?
NCT03978715 is a clinical study titled "The Effect of Implementing a Limb Loss Prevention Program on Amputation Rates". The investigators plan to do a retrospective chart review on patients admitted to Parkland Hospital with diabetic foot infections, ulcers, and bone injuries from 2005 (5 years prior to the start of the diabetic limb preservation team) to present day. The investigators will collect information on dem...
What is the current status of trial NCT03978715?
This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2021-04-14. Estimated completion is 2022-10-07.
What interventions are being tested in trial NCT03978715?
The interventions under investigation include: No intervention-retrospective study (OTHER).
Who is sponsoring clinical trial NCT03978715?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI